Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms HRS 5041, HRS-5041, HRS5041 |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Prostate Carcinoma | Phase 2 | China | 06 Sep 2024 | |
Metastatic castration-resistant prostate cancer | Phase 1 | China | 03 Aug 2023 | |
Advanced cancer | IND Approval | China | 18 Oct 2024 |